Educational content only. This post explains how financial concepts and published data apply generally to healthcare practices — it does not constitute advice for your specific situation. Figures referenced are from published industry sources. Consult your accountant, lender, and relevant advisors before making any significant business or financial decisions.
Most clinic startups don't fail because the owner wasn't a good clinician. They fail because someone committed to a lease before they had a clear picture of whether the economics actually worked — and by the time it became clear, the fixed costs were already locked in.
There are four numbers that, known before any commitment is made, put you in a fundamentally different position. Not because they make the decision — they don't — but because they reveal the shape of it. They define what you're actually deciding when you sign a lease, choose a fit-out scope, or approach a lender.
Number One: Total Startup Cost
Not the build-out number. Not the equipment quote. The total — all four categories combined: leasehold improvements, equipment, working capital reserve, and soft costs.
Most operators have a number in their head for the first two. Working capital is less frequently modelled before it becomes urgent. Soft costs — legal fees, permits, insurance premiums, EMR setup, signage, and contingency — are described in published healthcare startup guides as representing 8–15% of hard costs. On a $300,000 project, that's $24,000–$45,000 that doesn't show up in any contractor quote.
This number matters first because it sets the equity requirement. Published lending guidelines from programs like CSBFP in Canada and SBA 7(a) in the US describe equity contribution expectations typically in the 15–25% range of total project cost. You can't calculate 20% of a number you don't have.
Number Two: Break-Even Visit Volume
The number of patient visits per week required to cover monthly operating expenses — not to be profitable, not to service debt, just to not lose money on operations week to week.
The calculation is direct: monthly operating expenses divided by revenue per visit, divided by 4.33 weeks per month. What makes it meaningful is comparing it to what your specialty and market actually look like in the ramp period. Published healthcare practice development resources describe new clinics typically taking 12–18 months to reach stable volume — which means the break-even number needs to be achievable well before that point, or the working capital reserve is carrying the gap.
Published specialty benchmark data provides reference ranges for revenue per visit by specialty and billing model. Your specific fee schedule, payer mix, and market will determine where you actually land relative to those benchmarks.
Number Three: Equity Injection Ratio
Your personal capital contribution as a percentage of total startup cost.
This sits at the intersection of what you have and what lenders require. Published program minimums are in the 15–25% range; actual expectations depend on the program, the lender, and the application. What gets discussed less is the other half of this number — every dollar you inject is unavailable as personal financial buffer during the ramp period. The equity question isn't just "do I have enough to qualify?" It's "what is the right amount given my total picture?" That's a conversation for your accountant. But knowing your ratio precisely is where that conversation starts.
Number Four: Ramp-Adjusted Break-Even in Months
This is the one most startup models skip — and the one that bites hardest.
Not "when does the clinic break even at steady state?" but "how many months of shortfall do I need to fund before it gets there, and where does that money come from?" Published resources on clinic failure patterns consistently identify the ramp period — typically months 4–9, when fixed costs are fully running but volume hasn't caught up — as the highest-risk window. A clinic with a viable steady-state model can still fail in this window if the working capital reserve wasn't planned to bridge it.
This number is determined by your ramp-timeline assumption (informed by your specialty and referral network), your fixed cost structure, and the realistic volume trajectory. It feeds directly back into Number One — because the working capital required to bridge the ramp period is part of total startup cost.
Why These Four Connect
Total startup cost sets the equity requirement. The equity position determines how much is being financed and therefore what monthly debt service looks like. Monthly debt service affects break-even visit volume. Break-even visit volume relative to the ramp timeline determines how much working capital reserve is actually needed — which feeds back into total startup cost.
A business plan that calculates each of these independently, in separate sections, can show a healthy number in each section while the integrated picture is unworkable. The numbers need to talk to each other. That's not a financing insight or an accounting insight — it's a planning insight that's available to anyone who looks at all four at once.
Related: What Lenders Actually Look At When a Clinic Applies for Financing
Equipment leasing is one of three structures clinic operators use to finance clinical equipment — alongside outright purchase and term loans. Each produces a different monthly cash obligation, balance sheet profile, and total cost of ownership over the equipment life.
See how the scenarios compare in the Capital Structure Tool →Model startup cost ranges for your specialty and market — Canadian and US models built separately using published regional data. Get a phase-by-phase breakdown, equity injection analysis, and ramp-adjusted break-even. Three minutes, free.
Build Your Estimate →Disclaimer: All financial figures and ranges referenced in this post are from published industry sources — including professional association surveys, government program documentation, and published research — and represent general patterns across populations of practices. They are not estimates or projections for any specific practice. Results vary based on specialty, market, operator, and many other factors. KlinDeck is not a financial advisor, accountant, lender, or lawyer. The tools referenced are educational planning references only. Consult qualified professionals before making significant business or financial decisions.